Athero Review - Issue 3/2023
Guidelines
135
Clinical Studies
145
Anti-obesity drug with exceptional benefit for preventive cardiology: current results of the SELECT trial
Eva Tůmová, Michal Vrablík
153
VICTORY project: impact of complex pharmacotherapy on compensation of patients with type 2 diabetes mellitus
Martin Šatný, Michal Vrablík
165
Use of a fixed combination of ramipril with rosuvastatin in the management of lipitension: an observational study
Štefan Tóth, Dominika Zábavská
Reviews
172
Measuring lipoprotein(a) concentrations: what and how do we measure and where do we go from here?
Vladimír Soška, Ondřej Kyselák
177
New treatment possibilities of homozygous familial hypercholesterolemia
Vladimír Bláha, Marta Jordánová, Stanislav Zemek
185
Additional Cardiovascular Risk in Patients Living with HIV Associated with Antiretroviral Therapy
Bashir M. Maelin, Pavel Kraml
193
Šobrův den 2023: lipidová doba postmoderní
Kristýna Čillíková
195
Athero Review
2023 Issue 3
Most read in this issue
- Measuring lipoprotein(a) concentrations: what and how do we measure and where do we go from here?
- New treatment possibilities of homozygous familial hypercholesterolemia
- Anti-obesity drug with exceptional benefit for preventive cardiology: current results of the SELECT trial
- Use of a fixed combination of ramipril with rosuvastatin in the management of lipitension: an observational study